col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


56 Results       Page 1

 [1] 
Elsevier: Molecular Genetics and Metabolism
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―15 P.55 Innovation in metabolic nutrition: COVID-19 outreach to support patients on a low protein diet EM Stelle, L McGinty, KD Rowzer, R Finn
2 [GO] 2024―Apr―15 P.53 The effect of the Covid-19 pandemic on weight change and body mass index in children with inborn errors of metabolism L Nagy, S Belfaqeeh, M Inbar-Feigenberg
3 [GO] 2024―Apr―04 COVID-19 vaccine acceptance in individuals with PKU Matthew Mangel, Kimberly Parkin, Stephanie Sacharow
4 [GO] 2024―Jan―31 Patient-reported experiences during the SARS-CoV-2 (COVID-19): Results from a cross-sectional survey Sneha Patel, Lucy H.H. Parker, Sophie Thomas, Karolina M. Stepien, Stuart L. Forshaw-Hulme, Gisela Wilcox, Uma Ramaswami
5 [GO] 2023―May―11 COVID-19 in inherited metabolic disorders: Clinical features and risk factors for disease severity Ayça Burcu Kahraman, Yılmaz Yıldız, Kısmet Çıkı, Izzet Erdal, Halil Tuna Akar, Ali Dursun, et al. (+2)
6 [GO] 2023―Feb―27 Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19 Helison Rafael P. do Carmo, Marcos Y. Yoshinaga, Alejandro Rosell Castillo, Adriano de Britto Chaves-Filho, Isabella Bonilha, Joaquim Barreto, et al. (+19)
7 [GO] 2023―Feb―08 Transition to home infusion in Pompe disease in Brazil: Safety of the regimen during the COVID-19 pandemic and thereafter Dafne D.G. Horovitz, Anneliese L. Barth, Welton C. Alves, Juan C. Llerena
8 [GO] 2022―Oct―11 SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome Asako Takanohashi, Mohamad-Gabriel Alameh, Sarah Woidill, Julia Hacker, Benjamin Davis, Guy Helman, et al. (+12)
9 [GO] 2022―Sep―05 In vitro activity of cysteamine against SARS-CoV-2 variants Jess Thoene, Robert F. Gavin, Aaron Towne, Lauren Wattay, Maria Grazia Ferrari, Jennifer Navarrete, Ranajit Pal
10 [GO] 2022―May―01 Covid-19: Possible trigger of SLC13A3 reversible leukoencephalopathy relapse? Apolline Imbard, Julie Pernet, Clément Tarrano, Denis Lacroix, Monique Elmaleh-Bergès, Manuel Schiff
11 [GO] 2022―Mar―25 Examining the self-described impact of COVID-19 on the lives and interactions of adults with PKU R Powers, N Kuijper, P van de Hart, C Borre
12 [GO] 2022―Mar―18 BIOCHEMICAL LABORATORY ROTATION: OPTIMIZING EDUCATION DURING A PANDEMIC Tiffany Swaringer, Jessica Albert, Debra Regier
13 [GO] 2022―Mar―18 RISK MITIGATION BEHAVIORS TO PREVENT INFECTION IN THE MITOCHONDRIAL DISEASE COMMUNITY DURING THE COVID19 PANDEMIC Eliza Gordon-Lipkin, Shannon Kruk, Elizabeth Thompson, Chris Marcum, Peter McGuire
14 [GO] 2022―Feb―03 The impact of COVID-19 on Brazilian children with MPS: Advocate group perspective Maria Carolina F.A. Oliveira, Brianna D. Yund, Nathan Grant, Julie B. Eisengart, Roberto Giugliani
15 [GO] 2022―Feb―03 Effect of COVID19 pandemic on Argentinian Fabry and Gaucher patients Paula A. Rozenfeld, Isaac Kisinovsky
16 [GO] 2021―Aug―13 The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system Praveena Narayanan, Shiny Nair, Manisha Balwani, Maricar Malinis, Pramod Mistry
17 [GO] 2021―Jul―06 Issues of COVID-19-related distance learning for children with neuronopathic mucopolysaccharidoses Julie B. Eisengart, Amy N. Esler, N. Mathew Ellinwood, Rebekah L. Hudock, Kelly E. King, Terri L. Klein, et al. (+5)
18 [GO] 2021―Apr―09 Integrative analyses identify genes and their functional consequences underlying COVID-19 hospitalization Kritika Singh, Gita Pathak, Tyne Miller-Fleming, Frank Wendt, Nava Ehsan, Kangcheng Hou, et al. (+9)
19 [GO] 2021―Apr―09 Genetic modifiers of IL6 levels at baseline in COVID-19 infected patients Sandra Smieszek
20 [GO] 2021―Apr―09 Retrospective analysis of NGS data in pediatric genetic cohort: detection of rare variants that may impact influenza and COVID-19 infection Isabelle Thiffault, Emily Farrow, Ana Cohen, Tricia Zion, Shelby Neal, Warren Cheung, et al. (+11)
21 [GO] 2021―Apr―09 Impact of COVID-19 on newborn screening in South Texas Scott Ward, Laura Palmer Mackay, V. Reid Sutton, Kristian Divin
22 [GO] 2021―Apr―09 The impact of COVID-19 on pediatric diagnostic odysseys Margaret Waltz, Jeannette Bensen, Ann Katherine M. Foreman, Tracey Grant, Kristen Hassmiller Lich, Lonna Mollison, et al. (+2)
23 [GO] 2021―Apr―09 Clinical genetic counselor experience in the new/expanded adoption of telehealth in the US and Canada during the COVID-19 pandemic Daria Ma, Priyanka Ahimaz, Stephanie Cohen, Lola Cook, Jessica Giordano, Pooja Mohan, James Mirocha
24 [GO] 2021―Apr―09 Experiences of telemedicine in genetic practices during the COVID-19 pandemic Radhika Dhamija, Aaina Kochhar
25 [GO] 2021―Apr―09 Telemedicine challenges and strategies for the medical nutrition therapy of patients with inherited metabolic disorders during the COVID-19 pandemic Rani Singh, Theresa Pringle, Aileen Kenneson
26 [GO] 2021―Apr―09 Provision of reproductive and cancer genetics services during COVID-19 pandemic Andrew Wagner, Lee Shulman, Terri Lefler, Brittany DeGreef, Jeffrey Dungan
27 [GO] 2021―Apr―09 Prenatal genetic screening and diagnostic testing during the COVID-19 pandemic in the Bronx, NY Sara Rabin-Havt, Miranda Blanco-Breindel, Emily Suskin, Michelle Bina, Pe’er Dar, Susan Klugman
28 [GO] 2021―Apr―09 Extending and adapting the functions of genetic laboratories during the COVID-19 pandemic-challenges and successes Lora Bean, Eprem Chin, Ian Jarvis, Laura Schmitt, Dayle Blencowe, Bruno Ping, et al. (+9)
29 [GO] 2021―Apr―09 A comprehensive genome report for COVID-19 patients: GENCOV Study Canada Erika Frangione, Selina Casalino, Sunakshi Chowdhary, Chloe Mighton, Hanna Faghfoury, Yvonne Bombard, et al. (+8)
30 [GO] 2021―Apr―09 A genetic counselling protocol for the return of genomic sequencing and serological results to COVID-19 positive patients: GENCOV Study Canada Selina Casalino, Hanna Faghfoury, Sunakshi Chowdhary, Erika Frangione, Chloe Mighton, Yvonne Bombard, et al. (+2)
31 [GO] 2021―Apr―09 In silico analysis of similar protein sequences between Sars-Cov-2 and BCG vaccine Busra Goksel Tulgar, Fahrettin Duymus, Deniz Esin, Fatma Betul Maden, Ebru Marzioglu Ozdemir, Nadir Kocak
32 [GO] 2021―Apr―09 Newborn screening pilot study in time of pandemic: Duchenne Muscular Dystrophy pilot project experience Dorota Gruber, Wendy Chung, Julia Wynn, Lorraine Verdade, David Tegay, Michele Caggana, Norma Tavakoli
33 [GO] 2021―Feb―24 Gaucher disease in the COVID-19 pandemic environment: The good, the bad and the unknown Edward I. Ginns, Emory Ryan, Ellen Sidransky
34 [GO] 2021―Feb―01 Impact of COVID-19 on treatment and follow-up in patients with selected lysosomal diseases in a Brazilian center Ida V.D. Schwartz, Thiago O. Silva, Fabiano O. Poswar, Carolina F.M. Souza, Roberto Giugliani
35 [GO] 2021―Feb―01 Need leads to change: Transition to home infusion in Pompe disease in Brazil in the COVID-19 pandemic Dafne Dain Gandelman Horovitz, Anneliese Lopes Barth, Welton Correia Alves, Juan Clinton Llerena
36 [GO] 2021―Feb―01 Social distancing, home-infusion and oral therapy: Evolving paradigms on Gaucher disease management in Spain during COVID-19 pandemic Marcio M. Andrade-Campos, Beatriz Escuder Azuara, Conchita Perez-Valero, Laura Lopez de Frutos, Irene Serrano Gonzalo
37 [GO] 2021―Feb―01 COVID-19 pandemic impact on Brazilian patients with lysosomal diseases: A patient's perspective Ida V.D. Schwartz, Dévora N. Randon, Lethicia C. Ferraro, Carolina F.M. de Souza, Dafne D.G. Horovitz, Natan M. de Sá, Decio Brunoni
38 [GO] 2021―Feb―01 Measures to mitigate disruption due to the COVID-19 pandemic of the MODIFY phase 3 pivotal trial in patients with Fabry disease Aline Frey, Luba Trokan, Markus Vogler, Derralynn Hughes, Alberto Gimona
39 [GO] 2021―Feb―01 The impact of the COVID-19 pandemic on patients with inherited metabolic conditions: A survey in Wales Amanda Daniel, Vaughan Owens, Kate Maw
40 [GO] 2021―Feb―01 COVID-19 patient impact: A survey of the Gaucher community involving patients, caregivers and family members based in the US to determine impact of the pandemic Emory Ryan, Grisel Lopez, Manisha Balwani, Deborah Barbouth, T. Andrew Burrow, Edward Ginns, et al. (+15)
41 [GO] 2021―Feb―01 Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies Siddhee A. Sahasrabudhe, Mahmoud Al-Kofahi, James C. Cloyd, Neal Weinreb, Reena V. Kartha
42 [GO] 2021―Feb―01 Informing patients with rare diseases about COVID-19: Creation of the “Beto and the Coronavirus” booklet Matheus V. Wilke, Carolina Fischinger Moura de Souza, Roberto Giugliani, Ida V. Schwartz
43 [GO] 2021―Feb―01 Home treatment for lysosomal diseases during COVID-19: German experience Nesrin Karabul, Frank Rose, Gabriella Cipra
44 [GO] 2021―Feb―01 Fabry disease and COVID-19: International expert recommendations for management based on real-world experience Dawn A. Laney, Dominique P. Germain, João Paulo Oliveira, Alessandro P. Burlina, Gustavo H. Cabrera, Geu-Ru Hong, et al. (+7)
45 [GO] 2021―Feb―01 Impact of SARS-CoV-2 infection on Gaucher disease patients in Italy Maria Domenica Cappellini, Antonio Barbato, Francesca Carubbi, Maja Di Rocco, Fiorina Giona, Gaetano Giuffrida, et al. (+4)
46 [GO] 2021―Feb―01 Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York Luca Fierro, Nora Nesheiwat, Hetanshi Naik, Pramod K. Mistry, Manisha Balwani
47 [GO] 2021―Feb―01 Impact of SARS-CoV-2 on patients with lysosomal diseases in a major NYC hospital system Heather A. Lau
48 [GO] 2021―Feb―01 Impact of SARS-CoV-2 pandemic on the care for patients with lysosomal disorders: The experience of a Mexican pediatric center Carlos Patricio Acosta-Rodriguez-Bueno, Magdalena Cerón-Rodriguez, Daniela Castillo-Garcia
49 [GO] 2021―Feb―01 Impact of SARS-CoV-2 pandemic on the first Spanish national domiciliary enzymatic infusion strategy for lysosomal diseases Jorge Peris, María José Esteban, Jaqueline Robert, Philip Wikman, José Miguel Seguí, Ruth Cañizares, et al. (+9)
50 [GO] 2021―Feb―01 Neuronal ceroid lipofuscinosis assessment utilizing virtual visits during a pandemic Amy Vierhile, Grace A. Zimmerman, Margaux Masten, Camille Corre, Heather R. Adams, Jonathan W. Mink, Erika F. Augustine
51 [GO] 2020―Dec―17 Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York Luca Fierro, Nora Nesheiwat, Hetanshi Naik, Praveena Narayanan, Pramod K. Mistry, Manisha Balwani
52 [GO] 2020―Sep―25 The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective Mohamed A. Elmonem, Amaya Belanger-Quintana, Andrea Bordugo, Ritma Boruah, Elisenda Cortès-Saladelafont, Mounika Endrakanti, et al. (+14)
53 [GO] 2020―Jul―28 Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience Eleonora Riccio, Maurizio Pieroni, Giuseppe Limoneglli, Antonio Pisani
54 [GO] 2020―Jun―06 Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued Juan Politei
55 [GO] 2020―May―11 Gaucher disease and SARS-CoV-2 infection: Emerging management challenges Pramod Mistry, Manisha Balwani, Deborah Barbouth, T. Andrew Burrow, Edward I. Ginns, Ozlem Goker-Alpan, et al. (+14)
56 [GO] 2020―Apr―29 Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience Sechi Annalisa, Macor Daniela, Valent Serena, Da Riol Rosalia Maria, Zanatta Manuela, Spinelli Alessandro, et al. (+5)
 [1] 

56 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec